SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Valiant Laboratories informs about disclosure

21 Jun 2024 Evaluate
With reference to letter dated October 23, 2023, Valiant Laboratories has informed that the Board of Directors of the Company, vide resolution passed today have approved revision in the particulars of details provided to the exchange through above letter as mandated under SEBI Circular (SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123) dated July 13, 2023. The said revision is associated to the indicative time period for completion of the acquisition and has been revised from ‘On or before June 30, 2024’ to ‘On or before July 31, 2024’.

The above information is a part of company’s filings submitted to BSE.

Valiant Laboratories Share Price

67.00 0.30 (0.45%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×